Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Urology 2, 464–465 (1 October 2005) | doi:10.1038/ncpuro0280
Neoadjuvant androgen deprivation delays curative radiotherapy
Abstract
Martinez AA et al. (2005) Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Int J Radiat Oncol Biol Phys 62: 1322–1331 Short-term androgen deprivation confers no benefit in high-risk prostate cancer patients treated with high-dose radiotherapy, according to Martinez and colleagues.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
